NCT04192591: An ongoing trial by Boston Scientific Corporation
This trial is ongoing. It must report results 12 years, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04192591 |
|---|---|
| Title | A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 30, 2020 |
| Completion date | Feb. 28, 2038 |
| Required reporting date | Feb. 28, 2039, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |